Lyme + Co-infections Comprehensive 1 day
Our most comprehensive Lyme and co-infection combination panel includes Tickborne BBB Direct Detect dPCR with the Lyme Borrelia NanotrapĀ® urine antigen test to provide optimal coverage for the top flea and tick-borne infections at the genus level. Bartonella IgG Detect IFA adds enhances diagnostic accuracy when combined with BBB Direct Detect species genus level digital PCR Bartonella results.
Tickborne BBB Direct Detect ā dPCR (1 day or 3 day) and Lyme Borrelia Direct Detect ā NanotrapĀ® and Bartonella IgG Detect ā IFA
Tickborne BBB Direct Detect dPCR, confirms current infection by directly detecting genus-level DNA for a broad range of Bartonella, Borrelia, and Babesia species (spp) in whole blood. This approach ensures that less common species are not missed.
Lyme Borrelia Direct Detect ā Nanotrap assesses the current presence of Lyme Borrelia infection in urine. Concentrations of Lyme Borrelia are so low in the blood that a blood draw is unlikely to capture the pathogen in the test tube. The NanotrapĀ® test is targeting the OspA protein, which can be found on the surface of Borrelia species.
Bartonella IgG Detect IFA confirms antibodies against the four most common species of infection: Bartonella henselae, Bartonella koehlerae, Bartonella quintana, and Bartonella vinsonii berkhoffii.
Combining direct and indirect testing methodsāspecifically for Bartonella infectionāenhances diagnostic accuracy, especially for patients with complex clinical presentations. MosaicDX recommends maximizing diagnostic data by testing for both antibodies (indirect) and DNA evidence of pathogens (direct) for Bartonella, as each test method provides critical support. Tickborne BBB Direct Detect dPCR includes tests for Borrelia, Babesia and Bartonella at a genus level for all associated pathogens and Bartonella IgG Detect uses the IFA method to detect IgG to the top four Bartonella species affecting humans in North America.
We offer nine (9) individual tests and combinations of the most common Lyme and co-infections in North America, with options designed to meet every practitionerās need.
Patients presenting with flu-like symptoms, with or without Erythema migrans (EM) rash, and have lived or traveled to an area where Lyme disease is endemic.
Patients with chronic illness not improving, and past/present exposure to ticks, even with past treatment of Lyme, or Post-Treatment Lyme Disease Syndrome (PTLDS) or co-infections.
Patients with chronic illness not improving, and past/present exposure to ticks, fleas, lice, spiders or companion animals.
- Abdominal pain
- Anorexia
- Anxiety and depression
- Arthritis
- Bladder and pelvic pain
- Body aches
- Cardiovascular issues (endocarditis)
- Carditis or heart block
- Changes in bowel habits
- Depression
- Eye and vision problems (such as floaters, light sensitivity, and blurry vision)
- Facial pain and tooth issues
- Fatigue / chronic fatigue / profound fatigue
- Fever
- Fibromyalgia
- Flu-like illness
- Headaches
- Joint pain
- Localized or disseminated EM
- Malaise
- Muscle pain / soreness
- Muscle/limb impairment or paralysis
- Neurological manifestations
- Neurological symptoms such as facial paralysis, blindness
- Psychiatric symptoms (rage)
- Rash āstriaeā
- Seizures
- Sleeplessness
- Swollen lymph nodes in the head, neck, arms, and along the shins
Product Reviews
No reviews available for this product.